Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation

Background: Therapeutic/intermediate-dose heparin reduces the risk of thromboembolic events but increases the risk of major bleeding in patients hospitalized for acute COVID-19 pneumonia. Objectives: To prospectively assess the incidence of objectively proven venous thromboembolism (VTE) and identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Poletto, Francesco, Spiezia, Luca, Simion, Chiara, Campello, Elena, Dalla Valle, Fabio, Tormene, Daniela, Camporese, Giuseppe, Simioni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025628/
https://www.ncbi.nlm.nih.gov/pubmed/35458467
http://dx.doi.org/10.3390/v14040737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025628/
https://www.ncbi.nlm.nih.gov/pubmed/35458467
http://dx.doi.org/10.3390/v14040737

Ejemplares similares